Family Medicine · Palm Springs, FL
NPI
1881938819
Since 2012
Specialty
Family Medicine
Code 207Q00000X
Group practices
4
Medicare group memberships
Hospitals
0
Hospital affiliations
2601 10th Ave N
Palm Springs, FL, 33461
Phone (561) 642-1008
Groups this clinician bills Medicare through
Medicare paid, 2023
$16K
206 services
Medicare patients, 2023
45
Average age 67
Drug cost, 2024
$1.4M
1,807 prescriptions
Company payments, 2025
$2,241
From 14 companies
Procedures and visits billed to Original Medicare, 2023
In 2023, the most common Medicare service billed by Odiel Jean-Baptiste was code 99214 (office e&m - established), 104 times for 36 patients. In total Odiel Jean-Baptiste billed 206 services in 30 codes, and Medicare paid $16K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-02-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 104 | 36 | $89.64 | $9,323 |
| 99213 Office E&M - Established | Office | 13 | 13 | $56.41 | $733 |
By year: 2022 $25K for 363 services; 2023 $16K for 206 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 21 | 13 | $3.25 | $68.19 |
Medicare prescription drug claims, 2024
In 2024, the drug Odiel Jean-Baptiste prescribed most often to Medicare patients was Atorvastatin Calcium, with 96 prescriptions and refills. In total Odiel Jean-Baptiste wrote 1,807 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 96 | 252 | 41 | $947 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 85 | 85 | 15 | $352K |
| Amlodipine Besylate Generic | 78 | 205 | 30 | $526 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 64 | 64 | Under 11 | $254K |
| Losartan Potassium Generic | 64 | 176 | 25 | $676 |
| Metformin Hcl Generic | 51 | 146 | 23 | $490 |
| Prezcobix Darunavir/Cobicistat | 50 | 50 | Under 11 | $122K |
| Tivicay Dolutegravir Sodium | 50 | 50 | Under 11 | $124K |
| Gabapentin Generic | 50 | 62 | 15 | $493 |
| Dovato Dolutegravir Sodium/Lamivudine | 42 | 42 | Under 11 | $136K |
| Omeprazole Generic | 40 | 105 | 17 | $698 |
| Hydrochlorothiazide Generic | 39 | 107 | 14 | $213 |
| Nifedipine Er Nifedipine | 36 | 103 | 14 | $748 |
| Pantoprazole Sodium Generic | 32 | 80 | 14 | $327 |
| Descovy Emtricitabine/Tenofov Alafenam | 27 | 27 | Under 11 | $59K |
Brand drugs: 503 claims; generic drugs: 1,289 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Odiel Jean-Baptiste $2,241 ($2,241 in general payments such as food, travel and fees) from 14 companies. The largest payer was ViiV Healthcare Company with $1,083.
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company GSK | 40 | $1,083 |
| Gilead Sciences, Inc. GILD | 26 | $493 |
| Theratechnologies Inc. THTX | 6 | $200 |
| Indivior Inc. INDV | 4 | $120 |
| Lilly USA, LLC LLY | 3 | $55.33 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $51.96 |
| Braeburn Inc. | 3 | $50.59 |
| Merck Sharp & Dohme LLC MRK | 2 | $45.11 |
| Amgen Inc. AMGN | 2 | $36.23 |
| Neurocrine BioSciences, Inc. NBIX | 1 | $32.62 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.